Cargando…

Shexiang Baoxin Pill Corrects Metabolic Disorders in a Rat Model of Metabolic Syndrome by Targeting Mitochondria

Background: Metabolic syndrome (MS) is a global epidemic that has great socioeconomic and public health implications. This study reports observed effects of the Shexiang Baoxin Pill (SBP) in a rat model of MS and explores its underlying mechanisms of action. Methods: A diet-induced rat model of MS w...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Dan, Zheng, Ningning, Zheng, Lanyan, Wang, Leting, Song, Liang, Sun, Luning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841394/
https://www.ncbi.nlm.nih.gov/pubmed/29551973
http://dx.doi.org/10.3389/fphar.2018.00137
_version_ 1783304745584164864
author Wei, Dan
Zheng, Ningning
Zheng, Lanyan
Wang, Leting
Song, Liang
Sun, Luning
author_facet Wei, Dan
Zheng, Ningning
Zheng, Lanyan
Wang, Leting
Song, Liang
Sun, Luning
author_sort Wei, Dan
collection PubMed
description Background: Metabolic syndrome (MS) is a global epidemic that has great socioeconomic and public health implications. This study reports observed effects of the Shexiang Baoxin Pill (SBP) in a rat model of MS and explores its underlying mechanisms of action. Methods: A diet-induced rat model of MS was established according to accepted methods, and the rats were randomly divided into two groups: a control group (0.9% NaCl, 100 mg/kg(•)d) and a SBP-treated group (SBP, 100 mg/kg(•)d). Systolic blood pressures, fasting blood glucose (FBS) levels, triglyceride (TG) levels, high-density lipoprotein cholesterol (HDL-C) levels, body weights, and abdominal perimeters were dynamically monitored and analyzed. Serum leptin, adiponectin, TNF-α, IL-6, and IL-10 levels were measured by ELISA. Leptin, adiponectin, TNF-α, IL-6, and IL-10 expression in adipose tissue, as well as AMP-activated protein kinase (AMPK) and peroxisome proliferator-activated receptor gamma coactivator 1-α (PGC-1α) expression in heart, liver, skeletal muscle, and adipose tissue was measured by western blot. Expression of the mitochondrial protein UCP2, Cytochrome b and ATPase was observed by immunofluorescent staining. Results: SBP significantly decreased serum TG, TC, LDL-C levels and increased HDL-C levels. SBP also optimized the leptin/adiponectin ratio by decreasing leptin expression and increasing adiponectin expression in adipose tissue. SBP antagonized inflammatory reactions by promoting IL-10 expression in adipose tissue while inhibiting TNF-α and IL-6 expression. SBP improved lipid metabolism by up-regulating the expression of AMPK and PGC-1α. Furthermore, SBP decreased the severity of MS and its complications by adjusting the expression of several mitochondrial proteins, including UCP2, Cytochrome b and ATPase. Conclusion: SBP exhibits prominent therapeutic effects in the setting of MS. Possible mechanisms of action may be related to its anti-inflammatory and anti-oxidative characteristics, as well as its effects on improving lipid metabolism and protecting mitochondrial function.
format Online
Article
Text
id pubmed-5841394
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-58413942018-03-16 Shexiang Baoxin Pill Corrects Metabolic Disorders in a Rat Model of Metabolic Syndrome by Targeting Mitochondria Wei, Dan Zheng, Ningning Zheng, Lanyan Wang, Leting Song, Liang Sun, Luning Front Pharmacol Pharmacology Background: Metabolic syndrome (MS) is a global epidemic that has great socioeconomic and public health implications. This study reports observed effects of the Shexiang Baoxin Pill (SBP) in a rat model of MS and explores its underlying mechanisms of action. Methods: A diet-induced rat model of MS was established according to accepted methods, and the rats were randomly divided into two groups: a control group (0.9% NaCl, 100 mg/kg(•)d) and a SBP-treated group (SBP, 100 mg/kg(•)d). Systolic blood pressures, fasting blood glucose (FBS) levels, triglyceride (TG) levels, high-density lipoprotein cholesterol (HDL-C) levels, body weights, and abdominal perimeters were dynamically monitored and analyzed. Serum leptin, adiponectin, TNF-α, IL-6, and IL-10 levels were measured by ELISA. Leptin, adiponectin, TNF-α, IL-6, and IL-10 expression in adipose tissue, as well as AMP-activated protein kinase (AMPK) and peroxisome proliferator-activated receptor gamma coactivator 1-α (PGC-1α) expression in heart, liver, skeletal muscle, and adipose tissue was measured by western blot. Expression of the mitochondrial protein UCP2, Cytochrome b and ATPase was observed by immunofluorescent staining. Results: SBP significantly decreased serum TG, TC, LDL-C levels and increased HDL-C levels. SBP also optimized the leptin/adiponectin ratio by decreasing leptin expression and increasing adiponectin expression in adipose tissue. SBP antagonized inflammatory reactions by promoting IL-10 expression in adipose tissue while inhibiting TNF-α and IL-6 expression. SBP improved lipid metabolism by up-regulating the expression of AMPK and PGC-1α. Furthermore, SBP decreased the severity of MS and its complications by adjusting the expression of several mitochondrial proteins, including UCP2, Cytochrome b and ATPase. Conclusion: SBP exhibits prominent therapeutic effects in the setting of MS. Possible mechanisms of action may be related to its anti-inflammatory and anti-oxidative characteristics, as well as its effects on improving lipid metabolism and protecting mitochondrial function. Frontiers Media S.A. 2018-03-02 /pmc/articles/PMC5841394/ /pubmed/29551973 http://dx.doi.org/10.3389/fphar.2018.00137 Text en Copyright © 2018 Wei, Zheng, Zheng, Wang, Song and Sun. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Wei, Dan
Zheng, Ningning
Zheng, Lanyan
Wang, Leting
Song, Liang
Sun, Luning
Shexiang Baoxin Pill Corrects Metabolic Disorders in a Rat Model of Metabolic Syndrome by Targeting Mitochondria
title Shexiang Baoxin Pill Corrects Metabolic Disorders in a Rat Model of Metabolic Syndrome by Targeting Mitochondria
title_full Shexiang Baoxin Pill Corrects Metabolic Disorders in a Rat Model of Metabolic Syndrome by Targeting Mitochondria
title_fullStr Shexiang Baoxin Pill Corrects Metabolic Disorders in a Rat Model of Metabolic Syndrome by Targeting Mitochondria
title_full_unstemmed Shexiang Baoxin Pill Corrects Metabolic Disorders in a Rat Model of Metabolic Syndrome by Targeting Mitochondria
title_short Shexiang Baoxin Pill Corrects Metabolic Disorders in a Rat Model of Metabolic Syndrome by Targeting Mitochondria
title_sort shexiang baoxin pill corrects metabolic disorders in a rat model of metabolic syndrome by targeting mitochondria
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841394/
https://www.ncbi.nlm.nih.gov/pubmed/29551973
http://dx.doi.org/10.3389/fphar.2018.00137
work_keys_str_mv AT weidan shexiangbaoxinpillcorrectsmetabolicdisordersinaratmodelofmetabolicsyndromebytargetingmitochondria
AT zhengningning shexiangbaoxinpillcorrectsmetabolicdisordersinaratmodelofmetabolicsyndromebytargetingmitochondria
AT zhenglanyan shexiangbaoxinpillcorrectsmetabolicdisordersinaratmodelofmetabolicsyndromebytargetingmitochondria
AT wangleting shexiangbaoxinpillcorrectsmetabolicdisordersinaratmodelofmetabolicsyndromebytargetingmitochondria
AT songliang shexiangbaoxinpillcorrectsmetabolicdisordersinaratmodelofmetabolicsyndromebytargetingmitochondria
AT sunluning shexiangbaoxinpillcorrectsmetabolicdisordersinaratmodelofmetabolicsyndromebytargetingmitochondria